Lipocine Inc.
Hedge Funds Holdings
Last updated:
Lipocine Inc.‘s stocks are currently a part of 25 hedge funds’ portfolios, which represents 3.65% of the total amount of its stocks outstanding. This makes up a total of 3.24M shares of Lipocine Inc.. Compared to the previous quarter, the number fell by -69.09% or -7.25M shares fewer. As for the holding position changes, 20% (5) of current hedge fund investors increased the number of shares held, 20% (5) of current holders sold a part of the shares held, and 20% (5) closed the holdings completely. 5 hedge funds are new holders of Lipocine Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Lipocine (Q2 2018 – Q1 2023)
| Q2 2018 | 31 |
|---|---|
| Q3 2018 | 30 |
| Q4 2018 | 25 |
| Q1 2019 | 31 |
| Q2 2019 | 33 |
| Q3 2019 | 29 |
| Q4 2019 | 27 |
| Q1 2020 | 23 |
| Q2 2020 | 33 |
| Q3 2020 | 29 |
| Q4 2020 | 33 |
| Q1 2021 | 40 |
| Q2 2021 | 31 |
| Q3 2021 | 36 |
| Q4 2021 | 38 |
| Q1 2022 | 42 |
| Q2 2022 | 43 |
| Q3 2022 | 41 |
| Q4 2022 | 47 |
| Q1 2023 | 25 |
Hedge funds changes in Lipocine positions (Q2 2018 – Q1 2023)
| Q2 2018 | 8 | 6 | 11 | 5 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 9 | 10 | 1 | 10 |
| Q4 2018 | 3 | 4 | 9 | 8 | 1 |
| Q1 2019 | 9 | 6 | 5 | 3 | 8 |
| Q2 2019 | 5 | 6 | 10 | 3 | 9 |
| Q3 2019 | 3 | 7 | 7 | 7 | 5 |
| Q4 2019 | 7 | 8 | 4 | 9 | -1 |
| Q1 2020 | 5 | 5 | 5 | 7 | 1 |
| Q2 2020 | 14 | 7 | 3 | 5 | 4 |
| Q3 2020 | 7 | 10 | 3 | 11 | -2 |
| Q4 2020 | 10 | 10 | 3 | 6 | 4 |
| Q1 2021 | 14 | 10 | 9 | 7 | 0 |
| Q2 2021 | 4 | 12 | 4 | 13 | -2 |
| Q3 2021 | 7 | 10 | 7 | 2 | 10 |
| Q4 2021 | 8 | 8 | 12 | 6 | 4 |
| Q1 2022 | 8 | 13 | 7 | 4 | 10 |
| Q2 2022 | 9 | 9 | 11 | 9 | 5 |
| Q3 2022 | 6 | 5 | 9 | 8 | 13 |
| Q4 2022 | 10 | 6 | 11 | 3 | 17 |
| Q1 2023 | 5 | 5 | 5 | 5 | 5 |
Hedge funds changes in Lipocine stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 16,000 | 37,000 |
|---|---|---|
| Q3 2018 | 96,000 | 7,000 |
| Q4 2018 | 28,000 | 0 |
| Q1 2019 | 66,000 | 57,000 |
| Q2 2019 | 29,000 | 48,000 |
| Q3 2019 | 5,000 | 76,000 |
| Q4 2019 | 0 | 3,000 |
| Q1 2020 | 7,000 | 0 |
| Q2 2020 | 172,000 | 13,000 |
| Q3 2020 | 902,000 | 210,000 |
| Q4 2020 | 723,000 | 23,000 |
| Q1 2021 | 2,509,000 | 789,000 |
| Q2 2021 | 1,985,000 | 301,000 |
| Q3 2021 | 1,678,000 | 225,000 |
| Q4 2021 | 1,109,000 | 143,000 |
| Q1 2022 | 1,772,000 | 195,000 |
| Q2 2022 | 928,000 | 36,000 |
| Q3 2022 | 496,000 | 16,000 |
| Q4 2022 | 470,616 | 9,425 |
| Q1 2023 | 20,460,000 | 414,000 |